Salud financiera de hoja de balance de Ono Pharmaceutical
Salud financiera controles de criterios 5/6
Ono Pharmaceutical has a total shareholder equity of ¥788.1B and total debt of ¥150.0B, which brings its debt-to-equity ratio to 19%. Its total assets and total liabilities are ¥1,046.4B and ¥258.3B respectively. Ono Pharmaceutical's EBIT is ¥119.1B making its interest coverage ratio 2206.3. It has cash and short-term investments of ¥177.0B.
Información clave
19.0%
Ratio deuda-patrimonio
JP¥150.00b
Deuda
| Ratio de cobertura de intereses | 2206.3x |
| Efectivo | JP¥177.04b |
| Patrimonio | JP¥788.11b |
| Total pasivo | JP¥258.30b |
| Activos totales | JP¥1.05t |
Actualizaciones recientes sobre salud financiera
Recent updates
Ono Pharmaceutical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 03
We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt
Aug 25Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings
Jun 24Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00
Mar 04Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?
Feb 27Análisis de la situación financiera
Pasivos a corto plazo: 4528's short term assets (¥401.4B) exceed its short term liabilities (¥124.7B).
Pasivo a largo plazo: 4528's short term assets (¥401.4B) exceed its long term liabilities (¥133.6B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 4528 has more cash than its total debt.
Reducción de la deuda: 4528's debt to equity ratio has increased from 0% to 19% over the past 5 years.
Cobertura de la deuda: 4528's debt is well covered by operating cash flow (72.4%).
Cobertura de intereses: 4528's interest payments on its debt are well covered by EBIT (2206.3x coverage).